49 citations
,
January 2003 in “Clinical and Experimental Dermatology” The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.
5 citations
,
April 2019 in “Journal of The American Academy of Dermatology” Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.
1 citations
,
May 2025 in “Maturitas” The document examines the impact of menopause on hair loss in women, emphasizing hormonal changes such as decreased estrogen and increased androgens as key factors affecting hair growth. Conditions like female-pattern hair loss (FPHL) and telogen effluvium (TE) are common, while frontal fibrosing alopecia (FFA) is less frequent but can cause permanent hair loss. These changes can significantly affect emotional well-being and quality of life. Treatment options include medications like minoxidil, finasteride, and dutasteride, as well as low-power laser therapy and hair transplants. The review highlights the need for further research to better understand and address hair loss concerns in post-menopausal women. A study cited in the document found a 52.2% prevalence of FPHL among 178 participants, underscoring the widespread nature of this issue.
117 citations
,
March 2013 in “Journal of the European Academy of Dermatology and Venereology” No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.
29 citations
,
July 2010 in “Journal of Cutaneous Medicine and Surgery” Treatments for Frontal Fibrosing Alopecia have not been proven effective.